Do amoxicillin-clavulanate (Augmentin) and clarithromycin cause elevated liver enzymes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Do Augmentin and Clarithromycin Cause Elevated Liver Enzymes?

Yes, both amoxicillin-clavulanate (Augmentin) and clarithromycin are well-documented causes of elevated liver enzymes and can lead to clinically significant hepatotoxicity.

Clarithromycin Hepatotoxicity

Clarithromycin causes hepatic dysfunction including increased liver enzymes, and hepatocellular and/or cholestatic hepatitis, with or without jaundice 1. The FDA drug label explicitly warns that this hepatic dysfunction may be severe and is usually reversible, though hepatic failure with fatal outcomes has been reported 1.

Key Clinical Features:

  • Pattern: Both hepatocellular and cholestatic injury patterns
  • Severity: Can range from mild enzyme elevations to severe hepatitis with potential fatal hepatic failure
  • Reversibility: Usually reversible upon discontinuation
  • Warning signs: Anorexia, jaundice, dark urine, pruritus, or tender abdomen

Critical Action Point:

Discontinue clarithromycin immediately if signs and symptoms of hepatitis occur 1. This is a mandatory FDA-labeled warning, not a suggestion.

Amoxicillin-Clavulanate (Augmentin) Hepatotoxicity

Amoxicillin-clavulanate is the single leading drug involved in drug-induced liver injury (DILI) worldwide, representing 12.8-14% of all DILI cases 2. It is the most frequent cause of hospitalization for DILI 2.

Epidemiology and Risk:

  • Incidence: 9.91 per 100,000 users 2
  • Timing: Typically delayed onset (weeks after starting treatment) 3, 4
  • Pattern varies by age:
    • Younger patients: Predominantly hepatocellular pattern 2
    • Older patients: Cholestatic or mixed patterns 2

Clinical Presentations Documented:

  • Cholestatic hepatitis: Most common, can be severe with marked jaundice and pruritis 4
  • Hepatocellular injury: With ALT elevations exceeding 2000 U/L in severe cases 3
  • Pan-lobular hepatitis: Confirmed on biopsy 5
  • Mixed patterns: Can unmask underlying liver disease like primary biliary cholangitis 3

High-Risk Populations:

  • Males over 55 years old 5
  • Patients with alcohol consumption 5
  • Patients on concomitant hepatotoxic medications 3
  • Patients with diabetes or hypertension (for certain antibiotics) 6

Comparative Context

Among antibiotics causing DILI, amoxicillin-clavulanate stands out as having the highest absolute frequency 6, 2. While clarithromycin's hepatotoxicity is well-documented in FDA labeling, amoxicillin-clavulanate has more extensive epidemiological data showing it as the leading antibiotic cause of liver injury.

Clinical Management Algorithm

When prescribing either drug:

  1. Baseline assessment: Document baseline liver enzymes if patient has risk factors (age >55, alcohol use, concomitant hepatotoxic drugs, pre-existing liver disease)

  2. Patient education: Warn about symptoms of hepatitis (jaundice, dark urine, severe nausea, right upper quadrant pain, pruritis)

  3. If liver injury develops:

    • Immediate discontinuation of the offending antibiotic
    • Check ALT, AST, alkaline phosphatase, total and direct bilirubin, INR
    • Rule out viral hepatitis (especially hepatitis E), autoimmune causes, and other drug exposures
    • Monitor liver enzymes weekly until downtrending
  4. Contraindications: Clarithromycin is contraindicated in patients with history of cholestatic jaundice or hepatic dysfunction from prior clarithromycin use 1

Critical Pitfalls to Avoid

  • Don't dismiss early symptoms: Nausea and vomiting may precede overt jaundice by days 5
  • Don't rechallenge: Never re-prescribe these antibiotics to patients with prior hepatotoxicity from them
  • Don't ignore polypharmacy: Warfarin and other drugs can potentiate liver injury from these antibiotics 3
  • Don't assume rapid onset excludes DILI: While typically delayed, some cases present within days 7

The evidence is unequivocal: both drugs cause elevated liver enzymes and clinically significant hepatotoxicity, with amoxicillin-clavulanate being the most common antibiotic cause of DILI worldwide.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.